Diarylheptanoid from Pleuranthodium racemigerum with in vitro prostaglandin E2 inhibitory and cytotoxic activity

Hans Wohlmuth, Myrna A. Deseo, Don J. Brushett, Dion R. Thompson, Graham MacFarlane, Lesley M. Stevenson, David N. Leach

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Bioactivity-guided fractionation of an ethanolic extract of the rhizome of Pleuranthodium racemigerum, a tropical Zingiberaceae species from Northeastern Australia, resulted in the isolation and structural elucidation of 1-(4''-methoxyphenyl)-7-(4'-hydroxyphenyl)-(E)-hept-2-ene (1), a new diarylheptanoid related to curcumin. Compound 1 was a fairly potent inhibitor of prostaglandin E2 production in 3T3 murine fibroblasts (IC50 ≈ 34 μM) and also displayed moderate cytotoxicity against this cell line (IC50 = 52.8 μM). The compound also demonstrated cytotoxic activity against the P388D1 murine lymphoblast cell line (IC50 = 117.0 μM) and four human cell lines: Caco-2 colonic adenocarcinoma (IC50 = 44.8 μM), PC3 prostate adenocarcinoma (IC50 = 23.6 μM), HepG2 hepatocyte carcinoma (IC50 = 40.6 μM), and MCF7 mammary adenocarcinoma (IC50 = 56.9 μM). The cytotoxicity of compound 1 closely resembled that of curcumin, in terms of both IC50 values and dose-response curves.
    Original languageEnglish
    Pages (from-to)743-746
    Number of pages4
    JournalJournal of Natural Products
    Volume73
    Issue number4
    DOIs
    Publication statusPublished - 2010

    Keywords

    • Zingiberaceae
    • cell, mediated cytotoxicity
    • inhibitors
    • prostaglandins E

    Fingerprint

    Dive into the research topics of 'Diarylheptanoid from Pleuranthodium racemigerum with in vitro prostaglandin E2 inhibitory and cytotoxic activity'. Together they form a unique fingerprint.

    Cite this